The potential t response heterogeneity to human ApoB and CETP transgenes in LGMD2B might be of interest ase ApoB dyslipoproteinemia is also prevalent in hepatic steatosis, fibrosis, and fat infiltration [34–36]. This evidence concerns the gene APOB and Hepatic steatosis.